Dr. Sha Wei, female, Doctor of Medicine, Chief Physician, Professor at Tongji University, Doctoral Supervisor, and Shanghai Medical Leading Talent. She serves as the Director of the Tuberculosis Department and the Director of the Tuberculosis Clinical Research Center at Shanghai Pulmonary Hospital, affiliated with Tongji University. Professional Affiliations: Standing Committee Member of the Tuberculosis Branch of the Chinese Medical Association, Chairperson of the Tuberculosis Specialist Branch of the Shanghai Medical Association, Executive Council Member of the Chinese Antituberculosis Association, Chairperson of the Non-Tuberculous Mycobacteria Professional Branch of the Chinese Antituberculosis Association, Standing Committee Member of the Clinical Committee of the Chinese Antituberculosis Association, Vice President of the Shanghai Antituberculosis Association, Standing Committee Member of the Tuberculosis Branch of the China International Healthcare Promotion Association, Deputy Editor-in-Chief of the *Chinese Journal of Antituberculosis*, Member of the Expert Advisory Committee on Disease Prevention and Control of the National Health Commission, and Member of the National Tuberculosis Comprehensive Quality Control Expert Committee. International Training: July to October 2005, advanced training at the Berlin Lung Hospital in Germany; 2011–2012, visiting scholar at the New York University School of Medicine. Research Achievements: Principal investigator of 4 major national-level projects, including key R&D projects of the Ministry of Science and Technology, major national infectious disease projects, and sub-projects of the new drug creation program. In the past five years, she has published 34 SCI papers as first or corresponding author, obtained 4 authorized patents, and 1 software copyright. She has received one Second Prize of the Shanghai Medical Science and Technology Award and one Third Prize of the Huaxia Medical Science and Technology Award. Clinical Expertise: Specializes in the diagnosis, treatment, and interventional therapy of tuberculosis and non-tuberculous mycobacterial diseases, with particular expertise in the precise diagnosis and efficacy evaluation of smear-negative pulmonary tuberculosis, short-course and host immune-directed therapy for drug-resistant tuberculosis, and comprehensive treatment of severe non-tuberculous mycobacterial disease.